Montoya / Weiss Cannabis Use Disorders

1. Auflage 2018
ISBN: 978-3-319-90365-1
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 271 Seiten, eBook

This book is an unbiased scientific compendium documenting the state-of-the-art in the etiology, diagnosis and treatment of Cannabis Use Disorders (CUD). Unlike any other current medical text, this volume focuses on the scientific aspects of CUDs and provides a resource for researchers, physicians and other health care providers who treat patients suffering from the disorder or its consequences. It begins by establishing the landscape of the disorder, including its prevalence, association with disabilities and comorbidities, and frequency of patients seeking treatment. The text delves into the complexity of the disorder in today’s environment by including the discoveries on the nature and extent of the endocannabinoid system as well as potential breakthroughs in safe and effective pharmacological and nonpharmacological treatments. Experts in the field contribute discussions on the most cutting-edge diagnostic and biological topics, including genetics, medicalconsequences, and clinical manifestations. The text also covers the challenges and risks presented by external factors, including social repercussions, protective factors, psychiatric comorbidities, withdrawal, and treatment services.

Cannabis Use Disorders is a vital resource for researchers, psychiatrists, psychologists, addiction medicine specialists, toxicologists, hospital administrators, nurses, social workers, and all health care professionals working with patients who misuse cannabis.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Montoya, Ivan D.

Weiss, Susan R. B.

Inhaltsverzeichnis

Introduction.- Epidemiology of CUDs.- Genetics of CUDs.- The endocannabinoid system.- Effects of cannabis on the brain.- Medical consequences of cannabis use.- Social consequences of CUDs.- Cannabis use and psychomotor performance.- Psychiatric complication of CUDs.- Risks and protective factors for CUDs.- CUDs as a developmental disorder.- Clinical manifestations of CUDs.- Treatment targets for CUDs.- Cannabis withdrawal.- Animal models of CUDs.- Humal laboratory models of CUDs.- Non-Pharmacological Treatments of CUDs.- Cannabinoids to treat CUDs.- Non-cannabinoid treatments for CUDs .- Treatment of cannabis withdrawal.- Alternative medicine approaches to treat CUDs.- Treatment Services for CUDs.- Factors for CUD treatment reimbursement.

Über Autor(innen)

Ivan D. Montoya, M.D., M.P.H. Deputy Director, Division of Therapeutics and Medical Consequences National Institute on Drug Abuse – NIH 6001 Executive Blvd. Bethesda, MD 20892   Susan R.B. Weiss, Ph.D. Director, Division of Extramural Research National Institute on Drug Abuse 6001 Executive Boulevard Room 5274 MSC 9581 Bethesda, MD 20892-9581